| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.9B | $6.5B | $6.8B | $6.8B | $6.3B | $5.3B | $5.2B | $4.9B |
| Cost of Revenue | $3.3B | $3.0B | $3.4B | $3.1B | $2.9B | $2.5B | $2.4B | $2.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B | $0.5B | $0.4B | $0.4B |
| SG&A Expense | $1.7B | $1.6B | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B | $1.4B |
| Operating Income | $1.5B | $1.5B | $1.4B | $1.6B | $1.3B | $0.8B | $0.9B | $0.9B |
| Net Income | $1.3B | $1.3B | $1.2B | $1.3B | $1.2B | $0.7B | $1.1B | $0.3B |
| EPS (Basic) | $4.59 | $4.44 | $4.22 | $4.19 | $3.98 | $2.33 | $3.41 | $0.98 |
| EPS (Diluted) | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | $0.97 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.7B | $11.8B | $10.8B | $10.5B | $10.7B | $9.6B | $9.5B | $8.5B |
| Current Assets | $4.6B | $4.0B | $4.2B | $3.8B | $3.8B | $3.4B | $3.2B | $3.8B |
| Cash & Equivalents | $1.8B | $1.3B | $1.6B | $1.1B | $1.5B | $1.4B | $1.4B | $2.2B |
| Total Liabilities | $6.0B | $5.9B | $4.9B | $5.2B | $5.3B | $4.8B | $4.7B | $4.0B |
| Current Liabilities | $2.3B | $1.9B | $1.6B | $1.9B | $1.7B | $1.5B | $2.1B | $1.2B |
| Stockholders' Equity | $6.7B | $5.9B | $5.8B | $5.3B | $5.4B | $4.9B | $4.7B | $4.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.8B | $1.8B | $1.3B | $1.5B | $0.9B | $1.0B | $1.1B |
| Investing Cash Flow | $-0.4B | $-1.3B | $-0.3B | $-0.3B | $-0.7B | $-0.1B | $-1.6B | $-0.7B |
| Capital Expenditures | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.1B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.7B | $-0.8B | $-0.9B | $-1.4B | $-0.7B | $-0.7B | $-0.3B | $-0.8B |